REGADENOSON

Generic: REGADENOSON

International Medication SystemsManufacturer
INTRAVENOUSRoute
REGADENOSON ANHYDROUSActive Substance
2022-05-23Original Approval

REGADENOSON is FDA application ANDA214252, sponsored by IMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
HYPOTENSION
59 reports
2
NAUSEA
57 reports
3
DYSPNOEA
52 reports
4
HEADACHE
43 reports
5
CHEST PAIN
35 reports
6
DIZZINESS
34 reports
7
UNRESPONSIVE TO STIMULI
29 reports
8
CARDIAC ARREST
26 reports
9
BRADYCARDIA
25 reports
10
SEIZURE
24 reports